TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
7680684540011
CH-68454
R03DX11
03.04.5.
Reimbursement limitations:
TEZSPIRE
Le traitement exige une garantie de prise en charge des frais par la caisse maladie …
1 / 3
google
Details
- Product number
- 6845401
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad pH, aqua ad iniectabile, ad solutionem pro 1.91 ml.
Articles (1)
Tezspire, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
210.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1143.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2023
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68454
- Drug name
- Tezspire, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX11
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/06/2022
- Authorization expiration date
- 12/06/2027
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
- Description (DE)
- TEZSPIRE Inj Lös 210 mg/1.91ml Fertspr 1.91 ml
- Market launch
- 13/06/2022
- Narcotic (BTM)
- No